Delivery Order SPE2DR25D2100-SPE2DR26FA0DM
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,186.75 to AmerisourceBergen Drug Corp for 1,000 tablets of Topiramate 50 mg, with an ultimate completion date of November 19, 2025. This non-set-aside, competitively awarded contract employs firm fixed price pricing and represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion comprehensive pharmaceutical support vehicle running...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,789.72 for 500 tablets of Topiramate 25 mg, with a completion date of July 28, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a delivery order valued at $5,076.43 to AmerisourceBergen Drug Corp for 500 tablets of Topiramate 25 mg, with an ultimate completion date of August 28, 2025. This competitive award, executed on August 27, 2025, utilizes firm fixed pricing and carries no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 24, 2025, for the supply of Topiramate 100 mg tablets in quantities of 1,000 units, with a ceiling value of $1,171.44. This firm fixed-price delivery order, which is not set-aside for any socioeconomic program, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026....
- The Defense Logistics Agency awarded a delivery order valued at $5,177.90 to AmerisourceBergen Drug Corp for the supply of 500 tablets of Topiramate 25 mg. This contract, which was competitively awarded without set-aside designation, represents a firm fixed-price delivery order with an ultimate completion date of June 6, 2025. The vendor, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This award is a child contract derived from...
- The Defense Logistics Agency awarded a $7,809.77 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 500 tablets of Topiramate 25 mg, with an ultimate completion date of November 17, 2025. This non-competitive, non-set-aside delivery order represents a routine pharmaceutical procurement supporting federal medical supply needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order valued at $1,005.03 to AmerisourceBergen Drug Corp for the supply of 1,000 tablets of Topiramate 100 mg. This contract, issued on September 18, 2025, with an ultimate completion date of September 19, 2025, represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order operates under...
- The Defense Logistics Agency has awarded a delivery order valued at $35,132.55 to AmerisourceBergen Drug Corp for the supply of Topiramate 25 mg tablets in quantities of 500 units. This competitively awarded, firm fixed-price delivery order carries an ultimate completion date of August 5, 2025, and represents a non-set-aside procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Topiramate 100 mg tablets in quantities of 1,000 units, with a ceiling value of $1,732.79 and a firm fixed price contract type. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,101.91 to AmerisourceBergen Drug Corp for 1,000 tablets of Topiramate 100 mg, a generic anticonvulsant medication commonly used for seizure disorders and migraine prevention. This competitively awarded, firm fixed-price delivery order was established on October 15, 2025, with an ultimate completion date of October 16, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The contract contains...
- SPE2DR25D2100Indefinite Delivery Contract
- SPE2DR25D2100-SPE2DR26FA0DMDelivery Order
The Defense Logistics Agency awarded a competitively procured delivery order to AmerisourceBergen Drug Corp for 1,000 tablets of Topiramate 100 mg with a ceiling value of $8,140.65. The delivery order is firm fixed price and must be completed by November 19, 2025, with performance to be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award represents a child order under the company's broader Indefinite Delivery Contract with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999 through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving federal medical procurement needs across the Defense Health System and other government healthcare entities. The company was selected without set-aside restrictions, demonstrating its competitive capability to meet federal pharmaceutical supply requirements. This delivery order for Topiramate, a neurological medication commonly used for seizure management and migraine prevention, reflects the company's ongoing role as a critical supplier of brand-name and generic pharmaceuticals to military and veteran healthcare systems through the DLA's comprehensive pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.1k | 11/18/25 |